Cisplatinum-based chemotherapy in malignant mediastinal teratoma

Aust N Z J Surg. 1989 May;59(5):399-404. doi: 10.1111/j.1445-2197.1989.tb01594.x.

Abstract

Five patients with primary malignant mediastinal non-seminomatous germ cell tumours have been treated with a multimodality approach, including cisplatinum-containing chemotherapy, at this institution over the past 7 years. All patients had bulky disease (greater than 10 cm maximum diameter) at presentation and showed raised serum concentrations of human chorionic gonadotrophin or alpha-fetoprotein. Two patients are alive with no evidence of disease at 22 months and 6 years, respectively, from initial diagnosis; two patients have died from progressive disease and one from acute non-lymphocytic leukaemia without evidence of residual germ cell tumour. Long-term survival is achievable for these poor risk patients with a combined modality approach.

Publication types

  • Case Reports
  • Review

MeSH terms

  • Adult
  • Chorionic Gonadotropin / analysis
  • Cisplatin / therapeutic use*
  • Combined Modality Therapy
  • Humans
  • Male
  • Mediastinal Neoplasms / drug therapy*
  • Teratoma / drug therapy*
  • alpha-Fetoproteins / analysis

Substances

  • Chorionic Gonadotropin
  • alpha-Fetoproteins
  • Cisplatin